Tag: generic drugs

By Harriet Calvington
5 Comments

Antitrust Laws in Generic Drug Markets: How Competition Cuts Prices

Explore how antitrust laws shape generic drug markets, impacting prices and access. Learn about Hatch-Waxman, pay-for-delay deals, and global enforcement strategies.

7 Feb

By Harriet Calvington
15 Comments

FDA Orange Book: Where to Find Patent Expiration Dates for Generic Drugs

The FDA Orange Book is the official source for patent expiration dates of brand-name drugs in the U.S. Learn how to find and interpret these dates to predict when generic versions will become available.

6 Jan

By Harriet Calvington
10 Comments

Workers' Compensation: How Generic Substitution Lowers Costs Without Sacrificing Care

Generic substitution in workers' compensation cuts drug costs by up to 80% without reducing effectiveness. Learn how FDA-approved generics, state laws, and formularies are transforming occupational health care.

22 Nov

By Harriet Calvington
10 Comments

How Advertising Shapes Perceptions of Generic Drugs

Advertising for brand-name drugs influences patients to prefer expensive options over equally effective generics, driving up costs and distorting medical decisions-even when doctors know the generic is just as good.

19 Nov

By Harriet Calvington
10 Comments

Special Populations in Bioequivalence: Age and Sex Considerations

Bioequivalence studies must now account for age and sex differences to ensure generic drugs work safely for everyone. Learn how regulators are changing rules and why older adults and women are finally being included.

19 Nov

By Harriet Calvington
12 Comments

When Do Drug Patents Expire? Understanding the 20-Year Term and Real-World Timeline

Drug patents are often said to last 20 years, but in reality, most drugs have only 7-12 years of market exclusivity due to lengthy approval times. Learn how patent extensions, regulatory exclusivity, and layered protections affect when generics become available.